Showing 1461-1470 of 3134 results for "".
- Why I Sold: Dr. Brian Biesman Joins MedSpa Partnershttps://modernaesthetics.com/news/why-i-sold-dr-brian-biesman-joins-medspa-partners/2473487/Nashville-based oculofacial plastic surgeon Dr. Brian Biesman is joining MedSpa Partners (MSP) Inc. "I'm excited for us to join such a talented and accomplished group of practices and practitioners. We have always prided ourselves on our commitment to rigorously
- And the Winners Are ... Parents Magazine Announces Winners of Best Skin Care for Kids 2021https://modernaesthetics.com/news/and-the-winners-are-parents-magazine-announces-winners-of-best-skin-care-for-kids-2021/2473112/Meredith Corporation's Parents magazine released this year's Best Skin Care for Kids. Parents experts thoroughly tested nearly 300 formulas of parent recommendations, brand best-sellers, and new releases for skin and hair with 55 families. A total of 30 products that are a
- Legal Expert Discusses Industry Outlook for 2025https://modernaesthetics.com/news/legal-expert-discusses-industry-outlook-for-2025/2473729/As a partner in the law firm Michelman & Robinson's Commercial & Business Litigation Practice, Madison Dini has a well-informed perspective on the medical industry. Among other trends, Dini expects an uptick in mergers and acquisitions (M&A) activity within medtech and aesthetics in 2
- Plastic Surgery Foundation Opens Application for Aesthetic Plastic Surgery Research Granthttps://modernaesthetics.com/news/plastic-surgery-foundation-opens-application-for-aesthetic-plastic-surgery-research-grant/2473690/A grant opportunity is now available for plastic surgeons who are pursuing research in aesthetic and cosmetic plastic surgery. The Plastic Surgery Foundation opened applications for its Aesthetic Plastic Surgery Research Grant on Monday. The goals of the research m
- Revance Taps Erica Jordan as CCOhttps://modernaesthetics.com/news/revance-taps-erica-jordan-as-coo/2473522/Erica Jordan is now Revance Therapeutics, Inc.’s Chief Commercial Officer (CCO), Aesthetics. “Given the importance of the DAXXIFY launch, I’m excited to elevate Erica to the position of Chief Commercial Officer, Aesthetics reporting directly to me. Having wo
- Teyana Taylor Tapped as New Xeomin Brand Partnerhttps://modernaesthetics.com/news/teyana-taylor-tapped-as-new-xeomin-brand-partner/2473321/Xeomin, an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t. “I always strive to understand the ingredients in any product I’m using and listen to trusted so
- BeautyHealth’s Hydrafacial Teams Up with JLohttps://modernaesthetics.com/news/beautyhealths-hydrafacial-teams-up-with-jlo/2473309/The BeautyHealth Company is rolling out the Hydrafacial x JLo Beauty Booster. “I'm so excited to partner with Hydrafacial to create the new JLo Beauty Booster,” says founder of JLo Beauty Jennifer Lopez in a news release. “Hydrafacial is one of my favorite treatmen
- Candela Rolls Out Frax Prohttps://modernaesthetics.com/news/candela-rolls-out-frax-pro/2473047/Candela’s Frax Pro system is now available. This platform features Frax 1550 and the novel Frax 1940 applicators. The Frax 1940 handpiece delivers a 1940 nm wavelength laser beam for a shallow, epidermal approach, with focal reach extending to approximately 200 μm in
- Obagi Medical Acquires Novaestiq to Introduce HA Injectables in US Markethttps://modernaesthetics.com/news/obagi-medical-acquires-novaestiq-to-introduce-ha-injectables-in-us-market/2475814/Obagi Medical is set to expand into aesthetic injectables following the acquisition of Novaestiq Corp., the company behind the Saypha® ChIQ™ and Saypha® MagIQ™ hyaluronic acid (HA) filler products. The transaction was completed by Obagi’s parent company, Waldencast
- Study: CINDR of Masseter Muscle Optimal Injection Site for Botoxhttps://modernaesthetics.com/news/study-cindr-of-masseter-muscle-optimal-injection-site-for-botox/2475664/Research published in the Annals of Anatomy journal indicates the center of the intramuscular nerve dense region (CINDR) of the masseter muscle as the optimal botulinum neurotoxin A (BoNT-A) injection site. The researchers used 60 rabbits to assess BoNT-A injection efficacy at the CINDR.<